Codexis (CDXS) Current Deferred Revenue (2010 - 2026)
Codexis (CDXS) posted quarterly Current Deferred Revenue of $866000.0 for Q1 2026, down 6.68% year-over-year from $928000.0 in Q1 2025, and down 88.25% quarter-over-quarter from $7.4 million in Q4 2025.
Codexis (CDXS) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Codexis' Current Deferred Revenue history runs 17 years deep, the most recent figure standing at $866000.0 for Q1 2026.
- In Q1 2026, Current Deferred Revenue fell 6.68% year-over-year to $866000.0; the TTM figure through Mar 2026 stood at $866000.0 (down 6.68% YoY), while the FY2025 annual figure was $7.4 million, up 1537.56% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $866000.0, down from $7.4 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $30.6 million in Q4 2022, with the low at $100000.0 in Q2 2025.
- The 5-year median for Current Deferred Revenue is $5.4 million (2022), against an average of $8.1 million.
- Peak annual rise in Current Deferred Revenue reached 1537.56% in 2025, while the deepest fall reached 98.98% in 2025.
- Codexis' Current Deferred Revenue stood at $30.6 million in 2022, then sank by 95.75% to $1.3 million in 2023, then slumped by 65.38% to $450000.0 in 2024, then jumped by 1537.56% to $7.4 million in 2025, then tumbled by 88.25% to $866000.0 in 2026.
- Business Quant data shows CDXS's Current Deferred Revenue at $866000.0 in Q1 2026, $7.4 million in Q4 2025, and $396000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.75 Bn | 130.90 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.96 Bn | 77.96 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn |
| 4 | Moderna | 56.33 Bn | 51.19 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.56 Bn | 28.25 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - |
| 10 | Codexis | 152.51 Mn | 97.60 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 862,000.00 |
| Mar 31, 2026 | 866,000.00 |
| Dec 31, 2025 | 7.37 Mn |
| Sep 30, 2025 | 396,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 928,000.00 |
| Dec 31, 2024 | 450,000.00 |
| Sep 30, 2024 | 10.62 Mn |
| Jun 30, 2024 | 9.80 Mn |
| Mar 31, 2024 | 10.49 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 19.34 Mn |
| Jun 30, 2023 | 20.64 Mn |
| Mar 31, 2023 | 13.37 Mn |
| Dec 31, 2022 | 30.61 Mn |
| Sep 30, 2022 | 1.60 Mn |
| Jun 30, 2022 | 5.38 Mn |
| Mar 31, 2022 | 5.07 Mn |
| Dec 31, 2021 | 2.59 Mn |
| Sep 30, 2021 | 2.45 Mn |